The Department of Health has announced a significant expansion of the Respiratory Syncytial Virus (RSV) vaccination programme, aimed at reducing serious illness and hospitalisations among the most vulnerable.

Starting in April, the programme will be extended to include all adults over 80 years of age, while residents in care homes for older adults will begin receiving the jab later this month.

This move builds upon the initial adult programme launched in 2024, which focused on those aged 75 to 79. Unlike the seasonal flu or COVID-19 boosters, the RSV vaccine is a one-off dose that provides long-term protection without the need for an annual repeat. The expansion follows formal recommendations made by the Joint Committee on Vaccination and Immunisation (JCVI) in June 2025. Health Minister Mike Nesbitt highlighted that while RSV often presents as a mild cold, it can lead to severe complications in older populations. He noted that the vaccination not only protects individuals but also helps alleviate the sustained pressure on the Health and Social Care system. The Minister also reminded the public that a maternal RSV programme remains available for pregnant women to protect their infants from birth.

Chief Medical Officer Professor Sir Michael McBride warned that the virus is particularly dangerous for those with underlying chronic conditions, such as heart or lung disorders. He confirmed that the RSV vaccine can be safely administered alongside the COVID-19 vaccine. Many eligible people are expected to be offered both simultaneously during the upcoming rollout across April, May, and June.

Health officials are urging everyone eligible to take up the offer of the vaccine when contacted, stressing that immunisation remains the most effective way to prevent life-threatening complications.